Monday, 30 December 2019

Sol Gel's acne cream reduces marks in late-stage studies

Sol Gel Technologies Ltd said on Monday its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)